NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jeremy D Gale
Pfizer Inc. - New York / United States
Others
AD Scientific Index ID: 4397890
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jeremy D Gale's MOST POPULAR ARTICLES
1-)
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individualsfolkersennature metabolism 2 (10), 1135-1148, 20202372020
2-)
Effect of a second-generation α2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndromeLA Houghton, C Fell, PJ Whorwell, I Jones, DP Sudworth, JD GaleGut 56 (9), 1218-1225, 20072202007
3-)
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activityCJ Gardner, DR Armour, DT Beattie, JD Gale, AB Hawcock, GJ Kilpatrick, ...Regulatory peptides 65 (1), 45-53, 19961731996
4-)
GR113808: a novel, selective antagonist with high affinity at the 5‐HT4 receptorJD Gale, CJ Grossman, JWF Whitehead, AW Oxford, KT Bunce, ...British journal of pharmacology 111 (1), 332-338, 19941471994
5-)
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.CJ Gardner, DJ Twissell, TJ Dale, JD Gale, CC Jordan, GJ Kilpatrick, ...British journal of pharmacology 116 (8), 3158, 19951411995
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept